FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029796908> ?p ?o ?g. }

• W2029796908 endingPage "1765" @default.
• W2029796908 startingPage "1758" @default.
• W2029796908 abstract "BACKGROUND Survivors of childhood malignancies have an increased risk of developing second malignant neoplasms (SMN) due to their prior treatment and/or genetic susceptibility. A small proportion of SMNs are soft tissue sarcomas (STS), whose prognosis is generally thought to be poor, though publications on such patients' treatment and outcome is limited. METHODS The authors analyzed 25 patients who were registered for the Italian Cooperative Group protocols for pediatric STS from 1979 to 2000. The primary tumor was STS in five patients; Hodgkin disease in five patients; leukemia in four patients; retinoblastoma, neuroblastoma, and Wilms tumor in two patients each; and other tumor types in five patients. SMNs occurred after a median of 8 years (range, 1.9–15.0 years) and included rhabdomyosarcoma (RMS) in 4 patients, malignant peripheral nerve sheath tumor in 4 patients, extraosseous Ewing family tumor (EFT) in 4 patients, leiomyosarcoma in 3 patients, fibrosarcoma in 2 patients, synovial sarcoma in 2 patients, and other tumor types in 6 patients. Treatment generally was administered according to the guidelines for primary STS. RESULTS Seven non-RMS patients with STS underwent surgery alone, whereas 18 patients received chemotherapy and 8 patients received radiotherapy. Retreatment was feasible with acceptable toxicity. Fifteen patients were alive in complete remission of their SMN at the time of last follow-up. Responses to chemotherapy and survival were satisfactory for patients with tumors such as RMS and EFT. Complete tumor resection was correlated with a favorable prognosis in patients with other types of STS and in patients with postirradiation sarcoma. Two patients developed a third malignancy. CONCLUSIONS Although prior treatment may hinder the management of these patients, pediatric STS second malignancies can be cured using the same strategies used for de novo pediatric sarcomas. Long-term follow-up is mandatory given the risks of further malignancies and more severe, treatment-related side effects. Cancer 2004. © 2004 American Cancer Society." @default.
• W2029796908 created "2016-06-24" @default.
• W2029796908 creator A5006604201 @default.
• W2029796908 creator A5012553217 @default.
• W2029796908 creator A5024408605 @default.
• W2029796908 creator A5042223478 @default.
• W2029796908 creator A5053223108 @default.
• W2029796908 creator A5058003420 @default.
• W2029796908 creator A5062949757 @default.
• W2029796908 creator A5074834398 @default.
• W2029796908 creator A5075951287 @default.
• W2029796908 creator A5087672637 @default.
• W2029796908 date "2004-01-01" @default.
• W2029796908 modified "2023-10-16" @default.
• W2029796908 title "Soft tissue sarcoma as a second malignant neoplasm in the pediatric age group" @default.
• W2029796908 cites W1777354140 @default.
• W2029796908 cites W1975303234 @default.
• W2029796908 cites W1975307699 @default.
• W2029796908 cites W1976946790 @default.
• W2029796908 cites W1983809011 @default.
• W2029796908 cites W1988891734 @default.
• W2029796908 cites W2010267018 @default.
• W2029796908 cites W2012204906 @default.
• W2029796908 cites W2041712974 @default.
• W2029796908 cites W2044507524 @default.
• W2029796908 cites W2049153494 @default.
• W2029796908 cites W2086932478 @default.
• W2029796908 cites W2168571815 @default.
• W2029796908 cites W2342320434 @default.
• W2029796908 cites W4230870033 @default.
• W2029796908 cites W4251768308 @default.
• W2029796908 doi "https://doi.org/10.1002/cncr.20159" @default.
• W2029796908 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15073867" @default.
• W2029796908 hasPublicationYear "2004" @default.
• W2029796908 type Work @default.
• W2029796908 sameAs 2029796908 @default.
• W2029796908 citedByCount "43" @default.
• W2029796908 countsByYear W20297969082012 @default.
• W2029796908 countsByYear W20297969082013 @default.
• W2029796908 countsByYear W20297969082014 @default.
• W2029796908 countsByYear W20297969082015 @default.
• W2029796908 countsByYear W20297969082016 @default.
• W2029796908 countsByYear W20297969082017 @default.
• W2029796908 countsByYear W20297969082018 @default.
• W2029796908 countsByYear W20297969082020 @default.
• W2029796908 countsByYear W20297969082023 @default.
• W2029796908 crossrefType "journal-article" @default.
• W2029796908 hasAuthorship W2029796908A5006604201 @default.
• W2029796908 hasAuthorship W2029796908A5012553217 @default.
• W2029796908 hasAuthorship W2029796908A5024408605 @default.
• W2029796908 hasAuthorship W2029796908A5042223478 @default.
• W2029796908 hasAuthorship W2029796908A5053223108 @default.
• W2029796908 hasAuthorship W2029796908A5058003420 @default.
• W2029796908 hasAuthorship W2029796908A5062949757 @default.
• W2029796908 hasAuthorship W2029796908A5074834398 @default.
• W2029796908 hasAuthorship W2029796908A5075951287 @default.
• W2029796908 hasAuthorship W2029796908A5087672637 @default.
• W2029796908 hasBestOaLocation W20297969081 @default.
• W2029796908 hasConcept C121608353 @default.
• W2029796908 hasConcept C126322002 @default.
• W2029796908 hasConcept C141071460 @default.
• W2029796908 hasConcept C142724271 @default.
• W2029796908 hasConcept C143998085 @default.
• W2029796908 hasConcept C204232928 @default.
• W2029796908 hasConcept C2776694085 @default.
• W2029796908 hasConcept C2776715637 @default.
• W2029796908 hasConcept C2776910622 @default.
• W2029796908 hasConcept C2777532014 @default.
• W2029796908 hasConcept C2778173781 @default.
• W2029796908 hasConcept C2778256501 @default.
• W2029796908 hasConcept C2778629024 @default.
• W2029796908 hasConcept C2779013556 @default.
• W2029796908 hasConcept C2780283643 @default.
• W2029796908 hasConcept C2780844630 @default.
• W2029796908 hasConcept C509974204 @default.
• W2029796908 hasConcept C54355233 @default.
• W2029796908 hasConcept C71924100 @default.
• W2029796908 hasConcept C81885089 @default.
• W2029796908 hasConcept C86803240 @default.
• W2029796908 hasConceptScore W2029796908C121608353 @default.
• W2029796908 hasConceptScore W2029796908C126322002 @default.
• W2029796908 hasConceptScore W2029796908C141071460 @default.
• W2029796908 hasConceptScore W2029796908C142724271 @default.
• W2029796908 hasConceptScore W2029796908C143998085 @default.
• W2029796908 hasConceptScore W2029796908C204232928 @default.
• W2029796908 hasConceptScore W2029796908C2776694085 @default.
• W2029796908 hasConceptScore W2029796908C2776715637 @default.
• W2029796908 hasConceptScore W2029796908C2776910622 @default.
• W2029796908 hasConceptScore W2029796908C2777532014 @default.
• W2029796908 hasConceptScore W2029796908C2778173781 @default.
• W2029796908 hasConceptScore W2029796908C2778256501 @default.
• W2029796908 hasConceptScore W2029796908C2778629024 @default.
• W2029796908 hasConceptScore W2029796908C2779013556 @default.
• W2029796908 hasConceptScore W2029796908C2780283643 @default.
• W2029796908 hasConceptScore W2029796908C2780844630 @default.
• W2029796908 hasConceptScore W2029796908C509974204 @default.
• W2029796908 hasConceptScore W2029796908C54355233 @default.
• W2029796908 hasConceptScore W2029796908C71924100 @default.

• next